M. Selman (Mexico City, Mexico), V. Poletti (Forli, Italy)
Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis-usual interstitial pneumonia (IPF-UIP) using SELDI-mass spectrometry
E. Kriegova, C. Melle, F. Mrazek, B. Hutyrova, V. Kolek, R. M. du Bois, F. von Eggeling, M. Petrek (Olomouc, Czech Republic; Jena, Germany; London, United Kingdom)
|   |
Apoptosis, cell proliferation and angiogenesis in progression of different variants of idiopathic interstitial pneumonia (IIP)
S. Demoura, E. Kogan, V. Tuong (Moscow, Russian Federation)
| |
Evaluation of prostaglandin-E-main urinary metabolite (PGE-MUM) in idiopathic pulmonary fibrosis (IPF)
S. Ikushima, K. Morimoto, A. Arai, R. Ishikawa, A. Moriya, H. Kamiya, T. Ando, M. Fujiwara, M. Oritsu (Tokyo, Japan)
| |
Increased expression of epidermal growth factor-receptor in idiopathic interstitial pneumonias. A tissue microarray study
A. Tzouvelekis, E. Tsiambas, A. Karameris, G. Vilaras, P. Tzoumakari, M. Froudarakis, P. Steiropoulos, G. Drakonakis, D. Bouros (Alexandroupolis, Athens, Greece)
| |
Different expression profiles of gelsolin in various types of idiopathic interstitial pneumonias (IIPs). A tissue microarray study
A. Tzouvelekis, N. Oikonomou, A. Thanassopoulou, V. Aidinis, F. Konstantinou, D. Mikroulis, M. Froudarakis, A. Karameris, E. Tsiambas, D. Bouros (Alexandroupolis, Athens, Greece)
| |
VEGF expression does not differentiate between idiopathic pulmonary fibrosis and pulmonary sarcoidosis
K. Antoniou, F. Economidou, G. Soufla, E. Tzortzaki, I. Lambiri, N. Tzanakis, D. Spandidos, N. Siafakas (Heraklion, Greece)
| |
Protein kinase C and mitochondrial signaling mediate PM10-induced ROS and TGF-β expression in the bronchial epithelial cells
S. Y. Kyung, S. Y. Jeon, J. Y. Yun, Y. J. Kim, C. H. An, S. P. Lee, J. W. Park, S. H. Jeong, T. H. Moon, J. K. Lee (Incheon, Republic Of Korea)
| |
Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis
K. Antoniou, G. Soufla, E. Tzortzaki, M. Manousakis, G. Margaritopoulos, F. Economidou, I. Lambiri, D. Spandidos, N. Siafakas (Heraklion, Greece)
| |
Prognostic role of CCL18 serum concentrations in patients with idiopathic pulmonary fibrosis
A. Prasse, E. Bargagli, P. Rottoli, C. Probst, G. Zissel, J. Müller-Quernheim (Freiburg, Germany; Siena, Italy)
| |
Down regulation of human insulin-like growth factor in lung tissue of patients with idiopathic pulmonary fibrosis
K. Antoniou, G. Soufla, E. Tzortzaki, G. Sourvinos, I. Politis, I. Drositis, D. Spandidos, N. Siafakas (Heraklion, Greece)
| |
Understanding epithelial and extracellular matrix remodelling in an experimental model of usual interstitial pneumonia in mice
E. Parra, M. Capelozzi, G. Boufelli, J. Barbas-Filho, F. Costa, V. Capelozzi (São Paulo, Brazil)
| |
Non specific interstitial pneumonia in systemic sclerosis and idiopathic interstitial pneumonia: repair or remodeling process?
E. de Carvalho, E. Parra, A. Ab´Saber, R. Souza, R. Kairalla, V. Capelozzi (São Paulo, Brazil)
| |
Alteration of eicosanoid metabolism/signalling in IL-9 overexpressing mice and impact on lung fibrosis
S. van den Brule, C. Balsat, J. C. Renauld, B. Levy, D. Lison, F. Huaux (Brussels, Belgium; Boston, United States Of America)
| |
Abnormal coagulation and fibrinolysis in relation to deterioration of pulmonary function in idiopathic interstitial pneumonia
C. Ban, H. Dai, B. Pang, A. Cui, C. Wang (Beijing, China)
| |
The coagulation and antifibrynolitic activities are increased in the bronchoalveolar lavage fluid from patients with progressing idiopathic pulmonary fibrosis
J. Chorostowska-Wynimko, A. Rozy, K. Lewandowska, M. Korzeniewska, M. Franczuk, J. Kus, P. Kopinski (Warsaw, Bydgoszcz, Poland)
| |
Effects of rapamycin on bleomycin induced pulmonary fibrosis in rats and analysis of the underlying mechanism
X. Jin, C. Wang, H. Dai (Beijing, China)
| |
The histopathalogical evaluation of administration route of bleomycin in pulmonary fibrosis model and contribution of smoking to development of fibrosis
S. Yosunkaya, K. Uzun, H. Toy, E. Maden, T. Teke, F. Ozer, C. Boburan, C. Korkmaz (Konya, Turkey)
| |
aEb7 integrin (CD103-b7) expression in bronchoalveolar T lymphocytes in interstitial lung diseases
A. Morais, C. Palmares, L. Delgado, J. Moura e Sa (Porto, Gaia, Portugal)
| |